Literature DB >> 26398733

Perspective: Be clear about the real risks.

Matthew Hill1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26398733     DOI： 10.1038/525S14a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Genetic predisposition to schizophrenia associated with increased use of cannabis.

Authors:  R A Power; K J H Verweij; M Zuhair; G W Montgomery; A K Henders; A C Heath; P A F Madden; S E Medland; N R Wray; N G Martin
Journal:  Mol Psychiatry       Date:  2014-06-24       Impact factor: 15.992

2.  Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.

Authors:  S Andréasson; P Allebeck; A Engström; U Rydberg
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

Review 3.  Time trends in schizophrenia: changes in obstetric risk factors with industrialization.

Authors:  R Warner
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

4.  Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

Authors:  Marta Di Forti; Arianna Marconi; Elena Carra; Sara Fraietta; Antonella Trotta; Matteo Bonomo; Francesca Bianconi; Poonam Gardner-Sood; Jennifer O'Connor; Manuela Russo; Simona A Stilo; Tiago Reis Marques; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Fiona Gaughran; Zerrin Atakan; Conrad Iyegbe; John Powell; Craig Morgan; Michael Lynskey; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

Review 5.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

Authors:  Matthew Large; Swapnil Sharma; Michael T Compton; Tim Slade; Olav Nielssen
Journal:  Arch Gen Psychiatry       Date:  2011-02-07

6.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

7.  Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.

Authors:  Marta Di Forti; Conrad Iyegbe; Hannah Sallis; Anna Kolliakou; M Aurora Falcone; Alessandra Paparelli; Miriam Sirianni; Caterina La Cascia; Simona A Stilo; Tiago Reis Marques; Rowena Handley; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Craig Morgan; John Powell; Robin M Murray
Journal:  Biol Psychiatry       Date:  2012-07-24       Impact factor: 13.382

Review 8.  Why do patients with psychosis use cannabis and are they ready to change their use?

Authors:  Anna Kolliakou; Candice Joseph; Khalida Ismail; Zerrin Atakan; Robin M Murray
Journal:  Int J Dev Neurosci       Date:  2010-12-21       Impact factor: 2.457
  8 in total
  8 in total

1.  Cannabis: debated schizophrenia link.

Authors:  Matthew Large; Marta Di Forti; Robin Murray
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

2.  Cannabis: A potential efficacious intervention for PTSD or simply snake oil?

Authors:  Alfonso Abizaid; Zul Merali; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

3.  News Feature: Cannabis and the adolescent brain.

Authors:  Helen Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-07       Impact factor: 11.205

4.  Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Authors:  Robin M Murray; Harriet Quigley; Diego Quattrone; Amir Englund; Marta Di Forti
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

5.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

6.  The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

Authors:  Marta Di Forti; Diego Quattrone; Tom P Freeman; Giada Tripoli; Charlotte Gayer-Anderson; Harriet Quigley; Victoria Rodriguez; Hannah E Jongsma; Laura Ferraro; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Andrei Szöke; Celso Arango; Andrea Tortelli; Eva Velthorst; Miguel Bernardo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Jean-Paul Selten; Peter B Jones; James B Kirkbride; Bart Pf Rutten; Lieuwe de Haan; Pak C Sham; Jim van Os; Cathryn M Lewis; Michael Lynskey; Craig Morgan; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2019-03-19       Impact factor: 77.056

7.  Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis.

Authors:  Riccardo Bortoletto; Marco Colizzi
Journal:  Healthcare (Basel)       Date:  2022-08-16

8.  Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.

Authors:  Maximilian Gahr; Julia Ziller; Ferdinand Keller; Rainer Muche; Ulrich W Preuss; Carlos Schönfeldt-Lecuona
Journal:  Eur J Public Health       Date:  2022-04-01       Impact factor: 3.367
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.